Data Driven Bioscience provides integrated diagnostic kits and software for clinical cancer genomics, enabling precise cancer diagnosis through genomic analysis. The company addresses the need for accurate and efficient cancer detection by streamlining the testing process for healthcare providers.
Funding
$120K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical cancer genomics requires complex and time-consuming testing processes, creating challenges for healthcare providers seeking accurate and efficient cancer diagnoses. Existing diagnostic methods may lack the precision needed for personalized treatment strategies.
Solution
Data Driven Bioscience offers integrated diagnostic kits and software designed to streamline clinical cancer genomics workflows. The company's solutions enable precise cancer diagnosis through genomic analysis, providing healthcare providers with the tools needed for accurate and efficient cancer detection. By simplifying the testing process, Data Driven Bioscience aims to improve the speed and accuracy of cancer diagnoses, ultimately leading to better patient outcomes. The integrated approach combines diagnostic kits with user-friendly software, facilitating seamless data analysis and interpretation.
Target Audience
The primary target audience includes healthcare providers, clinical laboratories, and research institutions involved in cancer diagnostics and treatment.
Features
- Integrated diagnostic kits for various cancer types
- Software platform for genomic data analysis and interpretation
- Streamlined workflow for efficient testing processes
- Accurate and precise cancer diagnosis through genomic analysis